Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among... NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its lead product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.1301 | -11.8272727273 | 1.1 | 1.13 | 0.9699 | 118525 | 1.0713351 | CS |
| 4 | -0.1601 | -14.1681415929 | 1.13 | 1.23 | 0.9633 | 169913 | 1.10383726 | CS |
| 12 | -0.1901 | -16.3879310345 | 1.16 | 1.2899 | 0.9633 | 150366 | 1.11159414 | CS |
| 26 | -0.3001 | -23.6299212598 | 1.27 | 1.42 | 0.8 | 218622 | 1.14292973 | CS |
| 52 | -0.7601 | -43.936416185 | 1.73 | 2.25 | 0.512 | 242508 | 1.08753916 | CS |
| 156 | -3.1701 | -76.5724637681 | 4.14 | 5.2 | 0.4 | 659380 | 2.2365823 | CS |
| 260 | -3.5801 | -78.6835164835 | 4.55 | 8.18 | 0.4 | 915334 | 3.36357212 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
